BillionToOne, a molecular diagnostics company with a mission to create powerful and accurate tests accessible to all, announced today several abstract presentations that will be showcased at the ...

BioNTech is also working on various other therapeutic methods, including cell and gene therapies, antibodies, and chemical drugs ... spatial biology can determine where in a tissue or a single cell a ...

Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022.

AI is enabling the development of a next generation of drugs that can more precisely target cancer cells while sparing ...

“The transaction also facilitates the combination of different isotype functions into a single antibody molecule.” The deal expands Epsilogen’s pipeline with TigaTx’s TIGA-001—to be ...

The transaction also facilitates the combination of different isotype functions into a single antibody molecule. We are looking forward to working with our new colleagues in Boston and creating ...

The transaction also facilitates the combination of different isotype functions into a single antibody molecule. We are looking forward to working with our new colleagues in Boston and creating ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

and molecular profile information of disease-relevant targets – as well as the criteria that make for a successful antibody molecule, like affinity, specificity, and developability – to come ...

He also said that the merger opens up the prospect of combining different isotype functions into a single antibody molecule. These hybrid antibodies have the potential to activate multiple ...